IRTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
iRhythm Holdings, Inc (IRTC) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company shows strong revenue growth, its declining net income and EPS, coupled with hedge fund selling and lack of recent positive news or catalysts, suggest caution. The technical indicators and options data also do not present a compelling entry point. Holding off for now would be prudent.
The MACD is positive but contracting, indicating weakening bullish momentum. RSI is neutral at 49.901, showing no clear overbought or oversold conditions. The stock is trading near its pivot point at 121.409, with resistance at 126.703 and support at 116.116. Overall, the technical indicators suggest a neutral trend with no strong buy signal.
Strong revenue growth in Q4 2025 (+27.12% YoY). Analysts maintain a Buy rating despite lowering price targets, indicating long-term confidence in the company's growth potential.
Net income and EPS have significantly declined (-518.53% and -525.00% YoY, respectively). Hedge funds are selling heavily (+281.11% selling increase). No recent news or event-driven catalysts. DOJ investigation still ongoing, which may weigh on investor sentiment.
In Q4 2025, revenue increased by 27.12% YoY to $208.89M, showing strong top-line growth. However, net income dropped by -518.53% YoY to $5.58M, and EPS fell by -525.00% YoY to $0.17, indicating significant profitability challenges. Gross margin improved slightly to 70.88% (+1.23% YoY).
Analysts have lowered price targets across the board but maintain Buy ratings, reflecting cautious optimism. Recent price targets range from $155 to $215, with the latest adjustments reflecting sector-wide multiple compression and regulatory uncertainties. Analysts highlight potential revenue growth in 2027 with MCT approval as a long-term positive.
